OMelveny & Myers LLP
Two Embarcadero Center
San Francisco, CA 94111-3823
T: +1 415 984 8700
F: +1 415 984 8701
July 8, 2020
Ms. Tara Harkins
Ms. Jeanne Baker
Mr. David Lin, Esq.
Mr. Michael Clampitt, Esq.
Division of Corporation Finance
Office of Life Sciences Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Dear Ms. Harkins, Ms. Baker, Mr. Lin and Mr. Clampitt:
Nkarta, Inc. (File No. 333-239301)
Response to the Staffs Comments on Amendment No. 1 to Registration Statement on Form S-1 Filed on July 2, 2020
On behalf of our client, Nkarta, Inc., a Delaware corporation (the Company), we are hereby submitting to the staff (the Staff) of the Securities and Exchange Commission (the Commission) this letter setting forth the Companys responses to the comments contained in the Staffs letter dated July 7, 2020 regarding the Companys amendment no. 1 to the registration statement on Form S-1 filed via EDGAR to the Commission on July 2, 2020 (the Registration Statement).
Concurrently with the submission of this letter, the Company is filing its amended registration statement on Form S-1 (the Amended Registration Statement) and certain exhibits via EDGAR to the Commission for review.
The Staffs comments are repeated below in bold and are followed by the Companys responses. We have included page references in the Amended Registration Statement where the language addressing a particular comment appears. Capitalized terms used but not otherwise defined herein have the meanings set forth in the Amended Registration Statement.
Registration Statement on Form S-1
Capitalization, page 69
We note your response to prior comment 2 and that you removed your pro forma earnings per share information for the year ended December 31, 2019. Please revise to present pro forma earnings per share, basic and diluted, for the year ended December 31, 2019. Ensure you reflect the issuance of the second tranche
Century City Los Angeles Newport Beach New York San Francisco Silicon Valley Washington, DC
Beijing Brussels Hong Kong London Seoul Shanghai Singapore Tokyo
|of Series B convertible preferred stock as well as the conversion of all preferred stock. In this regard, we note that the second tranche of Series B convertible preferred stock should be reflected as being outstanding as of the beginning of the earliest pro forma period presented, which in your case is January 1, 2019. Refer to Article 11-02(c)(2)(i) of Regulation S-X.|
The Company has revised its disclosure on pages 11-12, 74-75 and 82 in response to the Staffs comment.
Statements of Operations and Comprehensive Loss, page F-4
We note your response to comment 3 and that you removed the pro forma net loss per share information for the year ended December 31, 2019. Please revise to include your pro forma net loss per share, basic and diluted, for the year ended December 31, 2019. Also, as previously requested, include a note on how you determined these amounts. Refer to Article 11-02(c)(2)(i) of Regulation S-X.
The Company has revised its disclosure on page F-4, F-8 and F-31 in response to the Staffs comment.
Please revise Exhibit 5.1 to quantify the number of shares that counsel is opining on. Also please revise to remove the assumptions that:
par value has been paid for the common stock; and
the issuance of shares will not exceed the total number of common stock available under your Certificate of Incorporation. Refer to Section II.B.3.a. of Staff Legal Bulletin No. 19.
Additionally, please advise us why it is appropriate for the opinion to assume registration of the shares by the transfer agent.
Concurrent with the filing herewith, the Company filed the Amended Registration Statement, which included a revised Exhibit 5.1 to quantify the number of shares that counsel is opining to, to remove the assumption of payment not less than per share par value, to remove the assumption of issuance in total numbers that do not exceed the total number of common stock available and to remove the assumption of registration of the shares by the transfer agent.
* * *
If you have any questions regarding the Amended Registration Statement, please contact Eric Sibbitt by telephone at 415-984-8777 or via e-mail at firstname.lastname@example.org, Sydney Ryan, by telephone at (415) 984-8908 or via email at email@example.com, or Frances D. Schulz, the audit engagement partner at Ernst & Young LLP, by telephone at 650-802-4510 or via email at firstname.lastname@example.org. Ernst & Young LLP is the independent registered public accounting firm of the Company.
Very truly yours,
/s/ Eric Sibbitt
cc: Paul Hastings, President and Chief Executive Officer of the Company
Dr. Matthew Plunkett, Chief Financial Officer of the Company
Sydney Ryan, Esq., Associate, OMelveny & Myers LLP
Frances D. Schulz, Partner, Ernst & Young LLP
Chris Forrester, Esq., Partner, Shearman & Sterling LLP